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Our Future in a 3-D Printer
By Ryan Cvelbar

CareCloud, a privately held technology company headquartered out of Miami, states that according to recent figures, the average cost of an organ
transplant in the U.S. can reach well over $1 million. Furthermore, according to the United Network
for Organ Sharing (UNOS), more than 113,000 patients in the U.S. are currently waiting for an organ
transplant. Anne Paschke of UNOS stresses this need
for organs by expressing that only 1 to 2 percent of
the population dies in a way that
makes them potential organ donors.
Although the need for organs has yet
to be met, bioprinting has the potential of saving lives by addressing this
chronic shortage through various applications.
Many of you may have heard
of 3-D printing, but have you heard
of bioprinting? Bioprinting is a biotechnology that does not fail to excite
optimists in the biotech industry.
Specifically, bioprinting is “an additive manufacturing process where
biomaterials such as hydrogels or
other polymers are combined with cells and growth
factors, and then printed to create tissue-like structures that imitate natural tissues” (What). You may be
wondering how exactly this printing process takes
place. Futurity explains that bioprinting involves using a computer-guided pipette that takes up cell cultures and “prints” them out in gel layers onto biopaper. This biopaper degrades over time; leaving behind the printed structure. According to the Australian Academy of Science (AAS), every tissue in the
body is naturally made up of different cell types, so
the required cells are taken from a patient and cultivated until there are enough to create cell specific
‘bio-ink’ that is loaded into the printer. Moreover, the
AAS explains how these cells seek out similar cells
to join with much like the way cells in an embryo develop in the womb during embryogenesis, or tissue in
an adult moves to repair damage. Because the parts
are synthesized from the organ recipient’s genetic
matter and precisely match the tissue or organ being
replaced, CareCloud states that there is less of a
chance that the immune system will reject the foreign

tissue. Now that we have covered the basics of sourcing, growing, and implanting bio-prints, let’s talk
about bioprinting’s potential applications.
From patient-specific surgical models and
personalized medicines to replacement body parts
and custom-made prosthetics, the possibilities of bioprinting are endless. A serious car accident that results in a passenger’s nose being shattered serves as a
great example of a situation in which bioprinting can
be put to use. According to the AAS, bioprinting technology makes it possible to
reconstruct this nose as a 3D model on the
computer. A biopsy can simultaneously be
performed on the patient while cartilage
cells are extracted from the knee, finger,
ear or splinters of the shattered nose. The
cells are reproduced in the laboratory and
mixed with a biopolymer, which is then
used to print a new nose to be implanted
during surgery. In this process, the biopolymer is used as a form of shaping mold
that is gradually broken down by the body
and replaced by its own cells. This replacement leaves the implant unrecognizable as it appears cohesive with the individual’s own
skin and cartilage. Moreover, Futurity forecasts that
mass-supplied prosthetics are likely to be a thing of
the past as 3D printing is increasingly used to manufacture prosthetics that are tailored to a patient’s anatomy and needs. For example, Futurity explains that
surgeons have to cut a patient’s bone to fit the prosthetic in a hip-replacement, but in the future, it will
be normal to 3D print a prosthetic to fit a patient. Additionally, bioprinting has extensive applications in
the pharmaceutical industry with the potential to
drastically reduce the need for animal trials in drug
testing. Cellink contends that this technology offers
the potential to test treatments for diseases using artificially affected tissues, eradicating organ donation
and transplantation. Perhaps bioprinting’s most significant application is the use of 3D printed models to
practice surgical operations. According to Jason
Chuen, Director of Vascular Surgery at Austin Health
and a Clinical Fellow at the University of Melbourne,
studies have shown that operations can be completed
faster and with less trauma for patients and the poten16

tial cost savings alone are considerable. Although
these ideas sound both exciting and feasible, professionals have a long way to go until these applications
become reality.
Aside from potential applications of bioprinting in the medical field, professionals are currently
making progress in the development of bioprinting as
it pertains to some similar applications. “In 2003,
Wake Forest succeeded in printing the first fully functional mini-kidney, which was able to filter blood and
produce urine. Since then, scientists have been working to develop more sophisticated organs like hearts,
livers and uteruses” (Carecloud). Chuen explains that
once inside the gel, cells can die in a matter of
minutes. This isn’t a problem for small structures like
organoids, an artificially grown organ, that can be
built quickly and then transferred back into a nutrient
solution, but it is a problem when attempting to print
an organ because the initial layers of cells will die before the organ is completed. Dave Fornell of Diagnostic and Interventional Cardiology argues that the
Achilles heel of tissue engineering today is the need
to create vascularity in the structure. He states that the
key to printing vascularizable micro-organs involves
chemical modifications of alginate hydrogels to promote organoid vascularity and suppress inflammatory
responses. According to Fornell, what we can print
right now are cardiac patches and small- to mediumsized blood vessels, skin tissue, soft tissue for reconstructive surgery, and vascularized micro-organs that
can be grown in a bioreactor and used to supplement
the function of a diseased organ like the liver.

ation, you can have a heart made out of your own cell
tissue. The biotechnology industry is growing at an
unprecedented rate and the prospects of bioprinting
applications like these give us a lot to look forward to.
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